Department of Pathology, All India Institute of Medical Sciences, New Delhi, 110029, India.
Department of Medical Oncology (DR. B.R.A. Institute Rotary Cancer Hospital), All India Institute of Medical Sciences, New Delhi, 110029, India.
Clin Exp Med. 2021 May;21(2):315-321. doi: 10.1007/s10238-021-00683-2. Epub 2021 Jan 22.
Lymphomas are a group of neoplasm arising from immune cells with varied clinical presentation, molecular profile, morphology and immunophenotype. The epidemiology and response to treatment varies among patients from different geographical locations. We analyze the demographic characteristics of lymphomas in a tertiary care center of India over a period of five years. This was a retrospective study including cases from 2015 to 2019 which were classified according to WHO classification 2017. A total of 4115 lymphoma cases were diagnosed. Hodgkin lymphomas (HL) comprised 30.35% (n = 1249), and non-Hodgkin lymphoma (NHL) was 69.65% (n = 2866). Site of presentation was nodal in 64.76% cases, and 35.23% were extranodal. There was an overall male predominance. Among the NHLs, B-cell type comprised of 84.08% and 15.38% was T- and NK cell lymphomas. Mature B cell lymphomas comprised 82.41% with predominant being diffuse large B cell lymphoma type (42.53%) followed by follicular lymphoma (10.81%) and small lymphocytic lymphoma (6.10%). Among the T-cell type, PTCL NOS (2.65%) was the predominant subtype followed by ALK positive anaplastic large cell lymphoma (ALCL-ALK+) (2.44%), extranodal NK-T cell lymphoma (2.02%) and others. Classical type was predominant type (97.91%) among HL, and 2.08% were nodular lymphocyte predominant type. Among the classical HL, nodular sclerosis (28.1%) and mixed cellularity (32.18%) co-dominated. Our study indicates that the Indian population differs in the prevalence, presentation and the subtyping among various lymphomas. Higher prevalence of Hodgkin lymphoma, DLBCL, ALK + ALCL and immature cell neoplasm was noted.
淋巴瘤是一组起源于免疫细胞的肿瘤,具有不同的临床表现、分子谱、形态学和免疫表型。不同地理位置的患者的流行病学和治疗反应存在差异。我们分析了印度一家三级护理中心五年间的淋巴瘤患者的人口统计学特征。这是一项回顾性研究,纳入了 2015 年至 2019 年的病例,根据 2017 年世界卫生组织分类进行了分类。共诊断出 4115 例淋巴瘤病例。霍奇金淋巴瘤(HL)占 30.35%(n=1249),非霍奇金淋巴瘤(NHL)占 69.65%(n=2866)。表现部位为淋巴结 64.76%,结外 35.23%。总体上男性居多。在 NHL 中,B 细胞类型占 84.08%,T 和 NK 细胞淋巴瘤占 15.38%。成熟 B 细胞淋巴瘤占 82.41%,其中弥漫性大 B 细胞淋巴瘤型(42.53%)最为常见,其次是滤泡淋巴瘤(10.81%)和小淋巴细胞淋巴瘤(6.10%)。在 T 细胞型中,PTCLNOS(2.65%)是最常见的亚型,其次是 ALK 阳性间变性大细胞淋巴瘤(ALK+ALCL)(2.44%)、结外 NK-T 细胞淋巴瘤(2.02%)和其他类型。HL 中经典型占主导地位(97.91%),结节性淋巴细胞为主型占 2.08%。在经典 HL 中,结节性硬化症(28.1%)和混合细胞型(32.18%)共同占主导地位。我们的研究表明,印度人群在各种淋巴瘤的流行率、表现和亚型方面存在差异。霍奇金淋巴瘤、弥漫性大 B 细胞淋巴瘤、ALK+间变性大细胞淋巴瘤和未成熟细胞肿瘤的患病率较高。